Candel Therapeutics (CADL) P/E (2021 - 2026)
Candel Therapeutics (CADL) P/E from Jul 27, 2021 to Jul 21, 2026. The TTM Candel Therapeutics (CADL) P/E is -10.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Candel Therapeutics (CADL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -10.75 | +29.38% |
| 2025 | -8.31 | +55.79% |
| 2024 | -5.33 | +300.17% |
| 2023 | -1.33 | -68.82% |
| 2022 | -4.27 | +7.27% |
| 2021 | -3.98 | N/A |
Comparison Candel Therapeutics (CADL) P/E with competitors
Candel Therapeutics (CADL) P/E is -10.75.